(NYSE: SCL) Stepan Co's forecast annual revenue growth rate of 1.82% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 4.5%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.55%.
Stepan Co's revenue in 2022 is $2,639,624,000.On average, 3 Wall Street analysts forecast SCL's revenue for 2022 to be $59,879,825,816, with the lowest SCL revenue forecast at $58,516,994,349, and the highest SCL revenue forecast at $60,589,122,718. On average, 3 Wall Street analysts forecast SCL's revenue for 2023 to be $59,625,549,569, with the lowest SCL revenue forecast at $56,007,689,274, and the highest SCL revenue forecast at $61,798,050,140.
In 2024, SCL is forecast to generate $63,805,494,200 in revenue, with the lowest revenue forecast at $63,805,494,200 and the highest revenue forecast at $63,805,494,200.